2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by (113)

Items 101–113 of 113

1. Neutrophils and circulating inflammatory biomarkers in diabetes mellitus and heart failure with preserved ejection fraction
   Chaar, Diana, Dumont, Benjamin L., Vulesevic, Branka, Neagoe, Paul-Eduard, Räkel, Agnès, White, Michel, Sirois, Martin G. · 2022 · The American Journal of Cardiology
2. High Central Venous Pressure after Cardiac Surgery Might Depict Hemodynamic Deterioration Associated with Increased Morbidity and Mortality
   Schiefenhövel, Fridtjof, Trauzeddel, Ralf F., Sander, Michael, Heringlake, Matthias, Groesdonk, Heinrich V., Grubitzsch, Herko, Kruppa, Jochen, Berger, Christian, Treskatsch, Sascha, Balzer, Felix · 2021 · Journal of Clinical Medicine
3. Heart Failure With Preserved Ejection Fraction: Prevention and Management
   Cilia, Lindsey, Saeed, Anum, Ganga, Harsha V., Wu, Wen-Chih · 2019 · American Journal of Lifestyle Medicine
4. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients—a systematic review and meta-analysis
   Siddiqui, Waqas Javed, Aggarwal, Sandeep, Rafique, Muhammad, Singh, Swaiman, Kutalek, Steven, Eisen, Howard J · 2018 · Heart Failure Reviews
5. Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation
   Urbanski, G, Chabrun, F, Lavigne, C, Lacout, C, Delattre, E, Reynier, P, Requin, J · 2024 · QJM: An International Journal of Medicine
6. Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction
   Grant, Andrew D.M., Chew, Derek S., Howlett, Jonathan G., Miller, Robert J.H. · 2020 · CJC Open
7. Myocardial Expression of the Anaphylatoxin Receptor C3aR is Associated with Cardiac Inflammation and Prognosis in Patients with Non-Ischaemic Heart Failure
   Mueller, Karin A.L., Patzelt, Johannes, Sauter, Manuela, Maier, Philipp, Gekeler, Sarah, Klingel, Karin, Kandolf, Reinhard, Seizer, Peter, Gawaz, Meinrad, Geisler, Tobias et al. · 2018 · ESC Heart Failure
8. B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
   de Falco, Renato, Vargas, Maria, Palma, Daniela, Savoia, Marcella, Miscioscia, Anna, Pinchera, Biagio, Vano, Martina, Servillo, Giuseppe, Gentile, Ivan, Fortunato, Giuliana · 2021 · Journal of Clinical Medicine
9. Pharmacological interventions effective in improving exercise capacity in heart failure
   Vitale, Cristiana, Spoletini, Ilaria, Rosano, Giuseppe MC · 2018 · Cardiac failure review
10. A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction
    Papworth, Monika, Kulkarni, Spoorthy, Antonsson, Madeleine, Sermadiras, Isabelle, Hovdal, Daniel, Connolly, Kathleen, Olsson, Jan, Shukla, Animesh, Cotton, Peter, Althage, Magnus et al. · 2025 · Cardiovascular Research
11. Blood pressure drops during hospitalization for acute heart failure treated with serelaxin: a patient-level analysis of 4 randomized controlled trials
    Grand, Johannes, Miger, Kristina, Sajadieh, Ahmad, Køber, Lars, Torp-Pedersen, Christian, Ertl, Georg, López-Sendón, José, Pietro Maggioni, Aldo, Teerlink, John R., Sato, Naoki et al. · 2022 · Circulation: Heart Failure
12. Editorial commentary: the CHA2DS2VASc score and its black and white items
    Fauchier, Laurent, Bodin, Alexandre, Bisson, Arnaud · 2019 · Trends in Cardiovascular Medicine
13. Myocarditis and Pericarditis
    Jain, Angita, Bruno, Katelyn A., Matsumori, Akira, Cooper, Leslie T., Yamani, Mohammad, Fairweather, DeLisa · 2022 · Comprehensive Pharmacology